Financhill
Back

Travere Therapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59

TVTX
Travere Therapeutics, Inc.

Last Price:
$30.4000
Seasonality Move:
-9.11%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Travere Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 29.38 Sell
20-day SMA: 30.22 Sell
50-day SMA: 32.84 Sell
200-day SMA: 24.79 Buy
8-day EMA: 11.34 Buy
20-day EMA: 5.2 Buy
50-day EMA: 2.2 Buy
200-day EMA: 0.57 Buy

Travere Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.06 Buy
Relative Strength Index (14 RSI): 44.76 Sell
Chaikin Money Flow: 2494712 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.3686 - 31.2886) Sell
Bollinger Bands (100): (27.721 - 35.941) Sell

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Travere Therapeutics, Inc. Stock

Is Travere Therapeutics, Inc. Stock a Buy?

TVTX Technical Analysis vs Fundamental Analysis

Buy
59
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy or a Sell?

Travere Therapeutics, Inc. Stock Info

Market Cap:
2.6B
Price in USD:
29.3500
Share Volume:
2.6M

Travere Therapeutics, Inc. 52-Week Range

52-Week High:
42.1300
52-Week Low:
12.9100
Buy
59
Travere Therapeutics, Inc. (TVTX) is a Buy

Travere Therapeutics, Inc. Share Price Forecast

Is Travere Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Travere Therapeutics, Inc.

Is Travere Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and an increase next year of $1.49 per share.

Technical Analysis of Travere Therapeutics, Inc.

Should I short Travere Therapeutics, Inc. stock?

* Travere Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.